Long-term Follow-up [hlca]
Combined [qlco]
Radiochemotherapy [topp]
Locally [spco]
Advanced [qlco]
Bladder carcinoma [neop]
Survival [acty]
Radiochemotherapy [topp]
Survival Rates [qnco]
toxicity [qlco]
Combined [qlco]
Radiochemotherapy [topp]
Consecutive [qlco]
Patients [podg]
Locally [spco]
Advanced [qlco]
Bladder carcinoma [neop]
Study [mnob]
Trial [resa]
Methods [inpr]
Consecutive [qlco]
Patients [podg]
Age [orga]
Muscle [tisu]
Invasive [qlco]
Locally [spco]
Advanced [qlco]
Bladder carcinoma [neop]
treated [topp]
Simultaneous [tmco]
Chemotherapy [topp]
Irradiation [npop]
Radiation [npop]
Administered [ftcn]
Fourth [qnco]
Ninth [qnco]
Tenth [qnco]
Interrupted [qlco]
Treatment Protocol [topp]
Cisplatin [inch, phsu]
Epirubicin [orch, phsu]
Radiosensitizers [phsu]
Radiation [npop]
Maximum [qnco]
Dose [qnco]
Irradiation [npop]
grays [qlco]
Patients [podg]
COMPLETED [qlco]
plan treatment [inpr]
Course [tmco]
Discontinue [fndg]
therapy [ftcn]
Patients [podg]
Myelosuppression [dsyn]
N NOS [aapp, imft]
severe symptoms [fndg]
gastrointestinal [spco]
N NOS [aapp, imft]
nephrotoxicity [inpo]
N NOS [aapp, imft]
Severe [qlco]
N NOS [aapp, imft]
Additional [ftcn]
Patients [podg]
stopped [qlco]
therapy [ftcn]
Vascular Diseases [dsyn]
treatment [ftcn]
toxicity [qlco]
Survival [acty]
AIL [neop]
Patients [podg]
La [elii]
Specific [qlco]
Survival [acty]
Patients [podg]
Alive [idcn]
Disease Progression [patf]
Received [qlco]
Incomplete [qnco]
therapy [ftcn]
toxicity [qlco]
AU [qnco]
Patients [podg]
Transurethral Resection [topp]
Superficial [spco]
Local [spco]
tumor recurrence [neop]
Conclusions [idcn]
Poor prognosis [fndg]
Group [idcn]
Patients [podg]
Invasive [qlco]
Locally [spco]
Advanced [qlco]
Bladder carcinoma [neop]
Limited [ftcn]
Specific [qlco]
Survival [acty]
Combined [qlco]
Radiochemotherapy [topp]
American Cancer Society [pros]
